From delayed reactive medical services to evidence-based Predictive, Preventive & Personalised Medicine.

Read more
‹ Back to overview

EPMA World Congress 2019


EPMA World Congress 2019, September 19-22 in Pilsen, Czech Republic            












 

Invitation to “EPMA Pilsen 2019”

 

Dear EPMA members, dear colleagues!

On behalf of the EPMA Board and the Congress Organising Committee we are pleased to invite you to participate in and actively contribute to the

 

5th EPMA World Congress dedicated to the

10th anniversary of the EPMA

September 19th – 22nd 2019
 

The meeting venue:

Hotel Primavera, Pilsen, Czech Republic

 

The scientific focus of the meeting is

Predictive, Preventive and Personalised Medicine

The key role of Biomarkers and Molecular biology

 

Prof. Dr. Ondrej Topolcan
Head of the Congress Organising Committee in Pilsen

 

Prof. Dr. Olga Golubnitschaja                            Dr. Vincenzo Costigliola 
EPMA Secretary-General                                        EPMA President

 

 

Specific Topics of the Congress:

  • Predictive medicine
    • Predictive biomarker panels
    • Multi-level diagnostics
    • Machine learning
    • Artificial intelligence
  • Preventive screening programs
    • Screening programs focused on pregnancy and newborns
    • Screening of rare diseases
    • Screening programs for endocrinologic and metabolic diseases
    • Population screening of cardiovascular and cerebrovascular diseases
  • Personalised medicine in Oncology
    • Recommended procedures for early diagnosis
    • The recommended procedures for treatment
    • Best practices for the follow-up and treatment monitoring
  • Biomarkers in diagnostics and the therapy effectiveness:
    • Prostate cancer
    • Liver and pancreatic cancers
    • Colorectal cancer
    • Breast Cancer
    • Lung Cancer
    • Ovarian cancer
  • Personalised medicine - neurodegenerative diseases
  • Personalised medicine - muscle and bone diseases
  • Sports
  • Biobanks
    • Stability of stored analytes
    • Quality control
    • Biobanks and development of new drugs